eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2023
vol. 9
 
Share:
Send email
Share:
abstract:
Original paper

Novel predictors of early atherosclerosis in nonalcoholic fatty liver disease

Badawy Abdulkhalik Abdulaziz
1
,
Ahmed Mahmoud Bendary
2
,
Aida Thabet
3
,
Eman Gamal Behery
3
,
Mona Salah
1
,
Medhat A Khalil
4
,
Ghadeer Rashad
1

  1. Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Benha University, Egypt
  2. Cardiovascular Medicine Department, Faculty of Medicine, Benha University, Egypt
  3. Clinical Pathology Department, Faculty of Medicine, Benha University, Egypt
  4. Internal Medicine Department, Faculty of Medicine, Benha University, Egypt
Clin Exp HEPATOL 2023; 9, 2: 106-114
DOI: https://doi.org/10.5114/ceh.2023.127466
Online publish date: 2023/06/05
View full text Get citation
 
PlumX metrics:
Aim of the study:
Non-alcoholic fatty liver disease (NAFLD) is regarded as the most relevant liver disease of the twenty-first century, affecting at least one third of the general population. NAFLD is associated with increased mortality due to cardiovascular disease (CVD) and cancer. The carotid intimal media thickness (CIMT), mean platelet volume (MPV) and endocan level could be markers for generalised atherosclerotic burden and endothelial dysfunction. The aims of the study were to evaluate the association between non-alcoholic fatty liver disease and early atherosclerosis by measuring CIMT, MPV and endocan level, as markers of endothelial dysfunction, in NAFLD patients.

Material and methods:
: This cross-sectional study included 50 patients who were divided into two groups: group I included 25 subjects with NAFLD and group II included 25 healthy subjects. Complete blood count with MPV, liver profile, lipid profile, fasting blood glucose level, 2-hour postprandial kidney function test, and serum concentrations of endocan were measured for all patients. NAFLD fibrosis score (NFS) was calculated. Abdominal ultrasonography and carotid ultrasound scan for measurement of CIMT were performed.

Results:
Serum endocan levels, MPV and CIMT were significantly higher (p < 0.005) in NAFLD patients (0.6, 9.3 ±1.2 and 0.9 ±0.3 respectively) than healthy subjects (0.1, 8.1 ±0.6 and 0.6 ±0.1 respectively). The analysis of diagnostic performance of these factors revealed that they have good sensitivity and specificity in prediction of endothelial dysfunction with AUC (0.950, 0.844 and 0.849 respectively).

Conclusions:
Serum endocan levels, MPV and CIMT could be considered as good predictors of endothelial dysfunction and therefore early detection of subclinical atherosclerosis in NAFLD patients.

keywords:

metabolic associated fatty liver disease, cardiovascular disease, carotid intimal media thickness, endocan, mean platelet volume
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.